High dose ascorbate supplementation fails to affect plasma homocyst(e)ine levels in patients with coronary heart disease
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 111 (2) , 267-270
- https://doi.org/10.1016/0021-9150(94)90101-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physiciansPublished by American Medical Association (AMA) ,1992
- Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factorsEuropean Journal of Clinical Investigation, 1992
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Plasma homocyst(e)ine levels in men with premature coronary artery diseaseJournal of the American College of Cardiology, 1990
- Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular diseaseMetabolism, 1988
- Folic acid—an innocuous means to reduce plasma homocysteineScandinavian Journal of Clinical and Laboratory Investigation, 1988
- Folic acid responsive postmenopausal homocysteinemiaMetabolism, 1985
- Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to PyridoxineNew England Journal of Medicine, 1983
- Homocysteine Metabolism in Scurvy, Growth and ArteriosclerosisNature, 1971